Key Developments: Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

811.20INR
26 Dec 2014
Price Change (% chg)

Rs6.50 (+0.81%)
Prev Close
Rs804.70
Open
Rs807.00
Day's High
Rs812.65
Day's Low
Rs804.00
Volume
84,807
Avg. Vol
192,502
52-wk High
Rs932.00
52-wk Low
Rs552.50

Search Stocks

Latest Key Developments (Source: Significant Developments)

Sun Pharmaceutical Industries Ltd updates on scheme of arrangement for Ranbaxy Laboratories Ltd
Monday, 24 Nov 2014 03:37am EST 

Sun Pharmaceutical Industries Ltd:Says the Hon'ble High Court of Gujarat, on Nov. 14, has sanctioned the scheme of arrangement in the nature of merger of Ranbaxy Laboratories Ltd with Sun Pharmaceutical Industries Ltd pursuant to its oral order uploaded on the web site of Hon’ble High Court of Gujarat on Nov. 21.  Full Article

Sun Pharmaceutical Industries Ltd and Merck & Co. Inc. enter into licensing agreement for Tildrakizumab
Wednesday, 17 Sep 2014 08:30am EDT 

Sun Pharmaceutical Industries Ltd and Merck & Co. Inc:Says through their respective subsidiaries, announced an exclusive worldwide licensing agreement for Merck's investigational therapeutic antibody candidate, tildrakizumab.Under terms, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront payment of US$80 mln.Merck will continue all clinical development and regulatory activities, which will be funded by Sun Pharma.Transaction is subject to customary closing conditions, including the requirements under the Hart Scott-Rodino Antitrust Improvements Act.  Full Article

Sun Pharmaceutical Industries Ltd's Caraco Pharmaceutical initiates recall of cephalexin capsules-Business Standard
Monday, 18 Aug 2014 03:25am EDT 

Sun Pharmaceutical Industries Ltd:Caraco Pharmaceutical Laboratories, the US-based unit of Sun Pharmaceuticals, has initiated a recall of multiple lots of cephalexin capsules from the US market, according to a PTI report-Business Standard.Citing a notification by the USFDA, the report says that the recall of the 340,553 units of 500 mg and 113,677 units of 250 mg bottles is voluntarily initiated by the company through a letter to the regulator in June under 'Class-II' classification.  Full Article

Sun Pharmaceutical Industries Ltd recommends payment of dividend
Tuesday, 12 Aug 2014 10:58pm EDT 

Sun Pharmaceutical Industries Ltd:Says board of Directors of the company have recommended payment of dividend of 1.50 indian rupees for the year ended Mar.31, 2014.  Full Article

Sun Pharmaceutical Industries Ltd Appoints Chief Financial Officer
Tuesday, 12 Aug 2014 10:45pm EDT 

Sun Pharmaceutical Industries Ltd:Appoints Uday Baldota as Chief Financial Officer (CFO) of Company with immediate effect.  Full Article

Sun Pharmaceutical Industries Ltd's subsidiary acquires Pharmalucence Inc
Tuesday, 15 Jul 2014 11:34pm EDT 

Sun Pharmaceutical Industries Ltd:Announces acquisition of Pharmalucence Inc, by one of its subsidiaries.Pharmalucence has sterile injectable capacity in the US, supported by R&D capabilities.Terms of the acquisition were not disclosed.  Full Article

Sun Pharmaceutical Industries Ltd's Caraco Pharmaceutical recalls antidepressant drug-Business Standard
Friday, 11 Jul 2014 02:30am EDT 

Sun Pharmaceutical Industries Ltd:Caraco Pharmaceutical Laboratories, a subsidiary of Sun Pharma, has initiated recall of some lots of Venlafaxine Hydrochloride extended-release tablets from the US market-Business Standard.According to a notification by the FDA, the recall of 26,530 units of 30-count bottles and 14,597 units of 90-count bottles is voluntarily initiated by the company through a letter to the regulator last month under 'Class-II' classification.  Full Article

Sun Pharmaceutical Industries Ltd recalls 200 vials of cancer drug-Business Standard
Thursday, 3 Jul 2014 02:42am EDT 

Sun Pharmaceutical Industries Ltd:Is recalling 200 vials of the chemotherapy drug gemcitabine in the United States due to a lack of assurance of sterility, the US Food and Drug Administration said-Business Standard.The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in Gujarat, the FDA said.  Full Article

Sun Pharmaceutical Industries Ltd gives FY 2015 revenue guidance in line with analysts' estimates - Conference Call
Thursday, 29 May 2014 03:00pm EDT 

Sun Pharmaceutical Industries Ltd:Expects FY 2015 consolidated revenues to grow by 13pct to 15pct.Reported revenue of 160 billion indian rupees in FY 2014.FY 2015 revenue of 183 billion indian rupees - Thomson Reuters I/B/E/S.  Full Article

Sun Pharmaceutical Industries Ltd announces settlement of litigation for generic Gleevec in US
Wednesday, 14 May 2014 11:08pm EDT 

Sun Pharmaceutical Industries Ltd:Says that one of its subsidiaries has executed a settlement agreement with Novartis Pharmaceuticals Corporation stipulating a dismissal of the lawsuits filed in the US against the company regarding submission of an ANDA for a generic version of Gleevec, Imatinib Mesylate tablets.Sun Pharma’s subsidiary may launch its version of generic Gleevec in the United States on Feb. 1, 2016.Other terms of the agreement are confidential.Agreement is subject to customary regulatory approvals.  Full Article

Deals of the day- Mergers and acquisitions

(Adds Mizuho, Oriola-KD, Sharp, Vattenfall, TriMas Corp, Abris Capital)

Search Stocks